Asian Journal Of Social Pharmacy

Asian Journal of Social Pharmacy

21 December 2024, Volume 19 Issue 4 Previous Issue   

Application of Real-World Evidence in the Approval of Antitumor Drugs

Shang Ya’nan, Huang Zhe

2024, 19 (4): 311–318;

Abstract ( 12 ) PDF (455KB) ( 6 )

Analysis of Innovations in Monitoring Adverse Drug Reaction and Application

Gong Jingyu, Tian Lijuan

2024, 19 (4): 319–326;

Abstract ( 3 ) PDF (361KB) ( 3 )

Research on the Construction of Drug Inspection Evaluation Indicator System

Hu Di, Liao Ping, Zhu Xin, Dai Yuemin, Ge Yuanyuan, Chen Yuwen

2024, 19 (4): 327–343;

Abstract ( 5 ) PDF (457KB) ( 2 )

Implementation of the Guidelines for Oncolytic Viruses in China

Meng Qinghe, Wang Shuling, Yang Mo

2024, 19 (4): 344–350;

Abstract ( 7 ) PDF (370KB) ( 2 )

Research on the Impact of the Centralized Drug Procurement Policy on China’s Pharmaceutical Enterprises

Miao Li, Tian Lijuan

2024, 19 (4): 351–360;

Abstract ( 6 ) PDF (1127KB) ( 2 )

Research on the Influence of Government R&D Funding and Enterprise R&D Investment on the Innovation Efficiency of Pharmaceutical Industry

Zhang Xuefeng, Jia Zheng, Fu Shuyong, Zhang Dawei, Xing Hua

2024, 19 (4): 361–370;

Abstract ( 2 ) PDF (453KB) ( 2 )

Analysis of Patents Related to COVID-19 - Based on Patent Clustering Model in Specific Fields

Fu Nan, Li Qian, Yuan Hongmei

2024, 19 (4): 371–382;

Abstract ( 6 ) PDF (3328KB) ( 2 )

Analysis of the Incidence and Risk Factors of Postoperative Infection in Patients with Class I Incisions Based on Literature Research

Wang Jinping, Sheng Qi, Zhao Jie, Wu Zhiang

2024, 19 (4): 383–389;

Abstract ( 8 ) PDF (469KB) ( 2 )

Visual Analysis of the Treatment for Soft Tissue Injury with TCM Based on CiteSpace

Su Haining, Duan Xiaoxiang, Wang Shuling

2024, 19 (4): 390–400;

Abstract ( 2 ) PDF (3371KB) ( 0 )

The Impact of Multimorbidity on Healthcare Utilization and Expenditure: Evidence from China

Ding Liman

2024, 19 (4): 401–408;

Abstract ( 3 ) PDF (371KB) ( 5 )